HERVs establish a distinct molecular subtype in stage II/III colorectal cancer with poor outcome
Home | Publication | HERVs establish a distinct molecular subtype in stage II/III colorectal cancer with poor outcome
Publications
75
+
Clinical Trials Ran
0
+
Approved Therapies
0